Literature DB >> 11132184

Human, but not bovine, oxidized cerebral spinal fluid lipoproteins disrupt neuronal microtubules.

M D Neely1, L L Swift, T J Montine.   

Abstract

Cerebral spinal fluid (CSF) lipoproteins have become a focus of research since the observation that inheritance of particular alleles of the apolipoprotein E gene affects the risk of Alzheimer's disease (AD). There is evidence of increased lipid peroxidation in CSF lipoproteins from patients with AD, but the biological significance of this observation is not known. A characteristic of the AD brain is a disturbance of the neuronal microtubule organization. We have shown previously that 4-hydroxy-2(E)-nonenal, a major product of lipid peroxidation, causes disruption of neuronal microtubules and therefore tested whether oxidized CSF lipoproteins had the same effect. We exposed Neuro 2A cells to human CSF lipoproteins and analyzed the microtubule organization by immunofluorescence. In vitro oxidized human CSF lipoproteins caused disruption of the microtubule network, while their native (nonoxidized) counterparts did not. Microtubule disruption was observed after short exposures (1 h) and lipoprotein concentrations were present in CSF (20 microg/mL), conditions that did not result in loss of cell viability. Importantly, adult bovine CSF lipoproteins, oxidized under identical conditions, had no effect on the microtubule organization of Neuro 2A cells. Comparison of human and bovine CSF lipoproteins revealed similar oxidation-induced modifications of apolipoproteins E and A-I as analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting. Fatty acid analysis revealed substantially lower amounts of unsaturated fatty acids in bovine CSF lipoproteins, when compared to their human counterparts. Our data therefore indicate that oxidized human CSF lipoproteins are detrimental to neuronal microtubules. This effect is species-specific, since equally oxidized bovine CSF lipoproteins left the neuronal microtubule organization unchanged.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11132184     DOI: 10.1007/s11745-000-0641-8

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  55 in total

1.  Opposing actions of native and oxidized lipoprotein on motor neuron-like cells.

Authors:  J N Keller; K B Hanni; W A Pedersen; N R Cashman; M P Mattson; S P Gabbita; V Friebe; W R Markesbery
Journal:  Exp Neurol       Date:  1999-05       Impact factor: 5.330

2.  Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo.

Authors:  C N Bassett; M D Neely; K R Sidell; W R Markesbery; L L Swift; T J Montine
Journal:  Lipids       Date:  1999-12       Impact factor: 1.880

Review 3.  Lipoprotein structure and metabolism.

Authors:  R L Jackson; J D Morrisett; A M Gotto
Journal:  Physiol Rev       Date:  1976-04       Impact factor: 37.312

4.  4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

Authors:  L M Sayre; D A Zelasko; P L Harris; G Perry; R G Salomon; M A Smith
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes.

Authors:  G W Rebeck; N C Alonzo; O Berezovska; S D Harr; R B Knowles; J H Growdon; B T Hyman; A J Mendez
Journal:  Exp Neurol       Date:  1998-01       Impact factor: 5.330

Review 7.  The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease.

Authors:  U Beffert; M Danik; P Krzywkowski; C Ramassamy; F Berrada; J Poirier
Journal:  Brain Res Brain Res Rev       Date:  1998-07

8.  PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL.

Authors:  W R MORRISON; L M SMITH
Journal:  J Lipid Res       Date:  1964-10       Impact factor: 5.922

Review 9.  Apolipoprotein E and Alzheimer disease.

Authors:  W J Strittmatter; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

10.  Neuronal transformations in Alzheimer's disease.

Authors:  J Metuzals; Y Robitaille; S Houghton; S Gauthier; C Y Kang; R Leblanc
Journal:  Cell Tissue Res       Date:  1988-05       Impact factor: 5.249

View more
  2 in total

1.  Oxidized low-density lipoprotein is present in astrocytes surrounding cerebral infarcts and stimulates astrocyte interleukin-6 secretion.

Authors:  Feng-Shiun Shie; M Diana Neely; Izumi Maezawa; Hope Wu; Sandy J Olson; Günther Jürgens; Kathleen S Montine; Thomas J Montine
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

2.  beta-Amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteins.

Authors:  Vidya V Kunjathoor; Anita A Tseng; Lea A Medeiros; Tayeba Khan; Kathryn J Moore
Journal:  J Neuroinflammation       Date:  2004-11-16       Impact factor: 8.322

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.